Your browser doesn't support javascript.
loading
Risk of COVID-19 after natural infection or vaccination.
Rick, Anne-Marie; Laurens, Matthew B; Huang, Ying; Yu, Chenchen; Martin, Thomas C S; Rodriguez, Carina A; Rostad, Christina A; Maboa, Rebone M; Baden, Lindsey R; El Sahly, Hana M; Grinsztejn, Beatriz; Gray, Glenda E; Gay, Cynthia L; Gilbert, Peter B; Janes, Holly E; Kublin, James G; Huang, Yunda; Leav, Brett; Hirsch, Ian; Struyf, Frank; Dunkle, Lisa M; Neuzil, Kathleen M; Corey, Lawrence; Goepfert, Paul A; Walsh, Stephen R; Follmann, Dean; Kotloff, Karen L.
Afiliación
  • Rick AM; Department of Pediatrics, University of Pittsburgh Medical Center, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA. Electronic address: anr169@pitt.edu.
  • Laurens MB; Department of Pediatrics, Center for Vaccine Development and Global Health, University of Maryland School of Medicine, Baltimore, MD, USA.
  • Huang Y; Fred Hutchinson Cancer Center, Seattle, WA, USA.
  • Yu C; Fred Hutchinson Cancer Center, Seattle, WA, USA.
  • Martin TCS; Department of Infectious Diseases and Global Public Health, University of California San Diego, San Diego, CA, USA.
  • Rodriguez CA; Morsani College of Medicine, University of South Florida, Tampa, FL, USA.
  • Rostad CA; Department of Pediatrics, Center for Childhood Infections and Vaccines, Children's Healthcare of Atlanta and Emory University School of Medicine, Atlanta, GA, USA.
  • Maboa RM; Ndlovu Research Centre, Limpopo, South Africa.
  • Baden LR; Brigham and Women's Hospital, Boston, MA, USA.
  • El Sahly HM; Baylor College of Medicine, Houston, TX, USA.
  • Grinsztejn B; Evandro Chagas National Institute of Infectious Diseases-Oswaldo Cruz Foundation, Rio de Janeiro, Brazil.
  • Gray GE; South African Medical Research Council, Cape Town, South Africa.
  • Gay CL; University of North Carolina School of Medicine, Chapel Hill, NC, USA.
  • Gilbert PB; Fred Hutchinson Cancer Center, Seattle, WA, USA.
  • Janes HE; Fred Hutchinson Cancer Center, Seattle, WA, USA.
  • Kublin JG; Fred Hutchinson Cancer Center, Seattle, WA, USA.
  • Huang Y; Fred Hutchinson Cancer Center, Seattle, WA, USA.
  • Leav B; Moderna, Inc., Cambridge, MA, USA.
  • Hirsch I; AstraZeneca BioPharmaceuticals, Cambridge, UK.
  • Struyf F; Janssen Research & Development, Beerse, Belgium.
  • Dunkle LM; Novavax, Inc., Gaithersburg, MD, USA.
  • Neuzil KM; Center for Vaccine Development and Global Health, University of Maryland School of Medicine, Baltimore, MD, USA.
  • Corey L; Fred Hutchinson Cancer Center, Seattle, WA, USA.
  • Goepfert PA; University of Alabama at Birmingham Heersink School of Medicine, Birmingham, AL, USA.
  • Walsh SR; Brigham & Women's Hospital and Harvard Medical School, Boston, MA, USA.
  • Follmann D; Biostatistics Research Branch, National Institute of Allergy and Infectious Diseases, Bethesda, MD, USA.
  • Kotloff KL; Department of Pediatrics, Center for Vaccine Development and Global Health, University of Maryland School of Medicine, Baltimore, MD, USA.
EBioMedicine ; 96: 104799, 2023 Oct.
Article en En | MEDLINE | ID: mdl-37738833
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Vacunas contra la COVID-19 / COVID-19 Tipo de estudio: Clinical_trials / Etiology_studies / Guideline / Risk_factors_studies Límite: Humans País/Región como asunto: America do norte Idioma: En Revista: EBioMedicine Año: 2023 Tipo del documento: Article Pais de publicación: Países Bajos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Vacunas contra la COVID-19 / COVID-19 Tipo de estudio: Clinical_trials / Etiology_studies / Guideline / Risk_factors_studies Límite: Humans País/Región como asunto: America do norte Idioma: En Revista: EBioMedicine Año: 2023 Tipo del documento: Article Pais de publicación: Países Bajos